Related Experiment Video

Updated: Jun 8, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Regulation of the mTOR signaling pathway: from laboratory bench to bedside and back again

Robert T Abraham1

  • 1Department of Oncology Discovery Research Wyeth, 401 N Middletown Road, Pearl River, NY 10965 USA. abrahar@wyeth.com

F1000 Biology Reports
|October 16, 2010
PubMed

Insights

Recent research advances our understanding of the mammalian target of rapamycin (mTOR) pathway, crucial for growth and metabolism. mTOR inhibitors show promise in treating diseases like cancer and diabetes.

Area of Science:

  • Molecular Biology
  • Cellular Metabolism
  • Disease Pathogenesis

Background:

  • The mammalian target of rapamycin (mTOR) signaling pathway regulates fundamental cellular processes like growth and metabolism.
  • Dysregulation of the mTOR pathway is implicated in numerous human diseases, including cancer, diabetes, and neurodegenerative disorders.
  • Rapamycin and its analogs are established mTOR inhibitors with demonstrated clinical utility.

Purpose of the Study:

  • To summarize recent progress in understanding the mTOR signaling pathway.
  • To highlight the role of mTOR dysregulation in human diseases.
  • To discuss the therapeutic potential of mTOR inhibitors.

Main Methods:

  • Review of recent scientific literature on mTOR signaling.
  • Analysis of clinical data on mTOR inhibitor efficacy.
  • Exploration of ongoing drug development for novel mTOR inhibitors.

Main Results:

  • Significant advancements have been made in elucidating the complexities of the mTOR pathway.
  • mTOR inhibitors have shown clinical efficacy in treating various mTOR-dysregulated diseases.
  • New mTOR inhibitors are under development, offering potential for future therapeutic applications.

Conclusions:

  • The mTOR pathway is a critical regulator of growth and metabolism with broad implications in human health and disease.
  • mTOR inhibitors represent a promising therapeutic strategy for a range of conditions.
  • Continued research into the mTOR network will facilitate the development of more targeted and effective treatments.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...